Therefore, despite the numerous evidences that C9ORF72 loss of function does not cause motor neuron disease without additional hits, targeting C9ORF72 haploinsufficiency early on in the disease course might be of strong therapeutic interest in C9ALS. This evidence concerns the gene C9orf72 and motor neuron disorder.